0001209191-20-020756.txt : 20200323 0001209191-20-020756.hdr.sgml : 20200323 20200323193335 ACCESSION NUMBER: 0001209191-20-020756 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200319 FILED AS OF DATE: 20200323 DATE AS OF CHANGE: 20200323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdollahian Neil CENTRAL INDEX KEY: 0001678223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 20736260 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-19 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001678223 Abdollahian Neil 6310 NANCY RIDGE DR SUITE 101 SAN DIEGO CA 92121 0 1 0 0 Chief Business Officer Employee Stock Option (right to buy) 1.98 2020-03-19 4 A 0 115000 0.00 A 2030-03-18 Common Stock 115000 115000 D The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19, 2020. /s/ Jessica Oien, Attorney-in-fact 2020-03-23